Constitutive and inducible clindamycin resistance among nosocomially acquired staphylococci;Nozokomiyal stafilokok izolatlarι arasιnda yapιsal ve indüklenebilir klindamisin direnci

Mikrobiyoloji Bulteni

Volumn 42, Issue 2, 2008, Pages 217-221

  Dizbay, Murat ^a   Günal, Özgür ^a   Özkan, Yavuz ^a   Özcan Kanat, Derya ^a   Altunçekiç, Arzu ^a   Arman, Dilek ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

Clindamycin; Coagulase negative staphylococci; D test; Resistance; Staphylococcus aureus

Indexed keywords

ANTIINFECTIVE AGENT; CLINDAMYCIN; COAGULASE;

ANTIBIOTIC RESISTANCE; ARTICLE; CROSS INFECTION; DRUG EFFECT; ENZYMOLOGY; HUMAN; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; CLINDAMYCIN; COAGULASE; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 52349124120     PISSN: 03749096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Fluit AC, Wielders CLC, Verhoef J, Schmitz FJ. Epidemiology and susceptibility of 3051 Staphylococcus aureus isolates from 25 university hospitals participating in the European SENTRY Study. J Clin Microbiol 2001; 39: 3727-32.
2. Lewis II JS, Jorgensen JH. Inducible clindamycin resistance in staphylococci: should clinicians and microbiologists be concerned? Clin Infect Dis 2005; 40: 280-5.
3. Fiebelkorn KR, Crawford SA, McElmeel ML, Jorgensen JH. Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci. J Clin Microbiol 2003; 41: 4740-4.
4. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. Fifteenth Informational Supplement. 2005, M100-S15. CLSI, Wayne, Pennsylvania.
5. Hamilton-Miller JM, Shah S. Patterns of phenotypic resistance to the macrolide-lincosamide-ketolide-streptogramin group of antibiotics in staphylococci. J Antimicrob Chemother 2000; 46: 941-9.
6. Siberry GK, Tekle T, Carroll K, Dick J. Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro. Clin Infect Dis 2003; 37:1257-60.
7. Levin TP, Suh B, Axelrod P, Truant AL, Fekete T. Potential clindamycin resistance in clindamycin-susceptible, erythromycin-resistant Staphylococcus aureus: report of a clinical failure. Antimicrob Agents Chemother 2005; 49:1222-4.
8. Schreckenberger PC, Ilendo E, Ristow KL. Incidence of constitutive and inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci in a community and a tertiary care hospital. J Clin Microbiol 2004; 42: 2777-9.
9. Azap OK, Arslan H, Timurkaynak F, Yapar G, Oruc E, Gagir U. Incidence of inducible clindamycin resistance in staphylococci: first results from Turkey. Clin Microb Infect 2005; 11: 582-4.
10. Delialioglu N, Aslan G, Ozturk C, Baki V, Sen S, Emekdas G. Inducible clindamycin resistance in staphylococcii isolated from clinical samples. Jpn J Infect Dis 2005; 58:104-6.
11. Dokuzoǧuz B. Metisiline dirençli Staphylococcus'a baǧli hastane enfeksiyonlarinin epidemiyolojisi ve kontrolü, s: 55-71. Ulusoy S, Usluer G, Ünal S (ed), Önemli ve Sorunlu Gram Pozitif Bakteri Enfeksiyonlari. 2004, Bilimsel Tip Yayinevi, Ankara.
12. National Nosocomial Infection Surveillance System (NNIS). NNIS System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004; 32: 470-85.